Skip to main content

Main menu

  • Home
  • Current issue
  • Early View
  • Archive
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • COVID-19 submission information
    • Institutional open access agreements
    • Peer reviewer login
  • Alerts
  • Subscriptions
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

User menu

  • Log in
  • Subscribe
  • Contact Us
  • My Cart

Search

  • Advanced search
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

Login

European Respiratory Society

Advanced Search

  • Home
  • Current issue
  • Early View
  • Archive
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • COVID-19 submission information
    • Institutional open access agreements
    • Peer reviewer login
  • Alerts
  • Subscriptions

Severe pulmonary hypertension associated with lung disease is characterised by a loss of small pulmonary vessels on quantitative CT

Dheyaa Alkhanfar, Yousef Shahin, Faisal Alandejani, Krit Dwivedi, Samer Alabed, Chris Johns, Allan Lawrie, AA Roger Thompson, Alexander MK Rothman, Juerg Tschirren, Johanna M Uthoff, Eric Hoffman, Robin Condliffe, Jim M Wild, David G Kiely, Andrew J Swift
ERJ Open Research 2022; DOI: 10.1183/23120541.00503-2021
Dheyaa Alkhanfar
1Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield, Sheffield, UK
2INSIGNEO, Institute for In Silico Medicine, University of Sheffield, Sheffield, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Dheyaa Alkhanfar
Yousef Shahin
1Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield, Sheffield, UK
3Department of Clinical Radiology, Sheffield Teaching Hospitals, Sheffield, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Yousef Shahin
Faisal Alandejani
1Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield, Sheffield, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Faisal Alandejani
Krit Dwivedi
1Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield, Sheffield, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Samer Alabed
1Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield, Sheffield, UK
3Department of Clinical Radiology, Sheffield Teaching Hospitals, Sheffield, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Samer Alabed
Chris Johns
3Department of Clinical Radiology, Sheffield Teaching Hospitals, Sheffield, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Allan Lawrie
1Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield, Sheffield, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Allan Lawrie
AA Roger Thompson
1Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield, Sheffield, UK
5Sheffield Pulmonary Vascular Disease Unit, Royal Hallamshire Hospital, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for AA Roger Thompson
Alexander MK Rothman
1Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield, Sheffield, UK
5Sheffield Pulmonary Vascular Disease Unit, Royal Hallamshire Hospital, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Juerg Tschirren
6VIDA Diagnostics Inc, Coralville, Iowa, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Johanna M Uthoff
7Department of Computer Science, University of Sheffield, Sheffield, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Eric Hoffman
4Department of Radiology, University of Iowa, Iowa, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Robin Condliffe
5Sheffield Pulmonary Vascular Disease Unit, Royal Hallamshire Hospital, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Robin Condliffe
Jim M Wild
1Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield, Sheffield, UK
2INSIGNEO, Institute for In Silico Medicine, University of Sheffield, Sheffield, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
David G Kiely
2INSIGNEO, Institute for In Silico Medicine, University of Sheffield, Sheffield, UK
5Sheffield Pulmonary Vascular Disease Unit, Royal Hallamshire Hospital, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK
8Both authors contributed equally
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for David G Kiely
Andrew J Swift
1Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield, Sheffield, UK
2INSIGNEO, Institute for In Silico Medicine, University of Sheffield, Sheffield, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: A.J.Swift@sheffield.ac.uk
  • Article
  • Info & Metrics
  • PDF
Loading

Abstract

Background Pulmonary hypertension (PH) in patients with chronic lung disease (CLD) predicts reduced functional status, clinical worsening and increased mortality, with patients with severe PH-CLD (≥35 mmHg) having a significantly worse prognosis than mild to moderate PH-CLD (21–34 mmHg). The aim of this cross-sectional study was to assess the association between computed tomography (CT) derived quantitative pulmonary vessel volume, PH severity and disease aetiology in CLD.

Methods Treatment naïve patients with CLD who underwent CT pulmonary angiography, lung function testing and right heart catheterisation were identified from the ASPIRE Registry between October 2012 and July 2018. Quantitative assessments of total pulmonary vessel and small pulmonary vessel volume were performed.

Results Ninety patients had PH-CLD including 44 associated with COPD/emphysema and 46 with interstitial lung disease. Patients with severe PH-CLD (n=40) had lower small pulmonary vessel volume compared to patients with mild to moderate PH-CLD (n=50). Patients with PH-ILD had significantly reduced small pulmonary blood vessel volume, compared to PH-COPD/emphysema. Higher mortality was identified in patients with lower small pulmonary vessel volume.

Conclusion Patients with severe PH-CLD, regardless of aetiology, have lower small pulmonary vessel volume compared to patients with mild-moderate PH-CLD and this is associated with a higher mortality. Whether pulmonary vessel changes quantified by CT are a marker of remodelling of the distal pulmonary vasculature requires further study.

Footnotes

This manuscript has recently been accepted for publication in the ERJ Open Research. It is published here in its accepted form prior to copyediting and typesetting by our production team. After these production processes are complete and the authors have approved the resulting proofs, the article will move to the latest issue of the ERJOR online. Please open or download the PDF to view this article.

Conflict of interest: Dr. Alkhanfar has nothing to disclose.

Conflict of interest: Dr. Shahin has nothing to disclose.

Conflict of interest: Dr. Alandejani has nothing to disclose.

Conflict of interest: Dr. Dwivedi has nothing to disclose.

Conflict of interest: Dr. Alabed has nothing to disclose.

Conflict of interest: Dr. Johns has nothing to disclose.

Conflict of interest: Dr. Lawrie has nothing to disclose.

Conflict of interest: Dr. Thompson has nothing to disclose.

Conflict of interest: Dr. Rothman has nothing to disclose.

Conflict of interest: Dr. Tschirren has nothing to disclose.

Conflict of interest: Dr. Uthoff has nothing to disclose.

Conflict of interest: Dr. Hoffman has nothing to disclose.

Conflict of interest: Dr. Condliffe has nothing to disclose.

Conflict of interest: Dr. Wild has nothing to disclose.

Conflict of interest: Dr. Kiely has nothing to disclose.

Conflict of interest: Dr. Swift has nothing to disclose.

This is a PDF-only article. Please click on the PDF link above to read it.

  • Received August 13, 2021.
  • Accepted February 10, 2022.
  • Copyright ©The authors 2022
http://creativecommons.org/licenses/by-nc/4.0/

This version is distributed under the terms of the Creative Commons Attribution Non-Commercial Licence 4.0. For commercial reproduction rights and permissions contact permissions{at}ersnet.org

PreviousNext
Back to top
Vol 8 Issue 3 Table of Contents
ERJ Open Research: 8 (3)
  • Table of Contents
  • Index by author
Email

Thank you for your interest in spreading the word on European Respiratory Society .

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Severe pulmonary hypertension associated with lung disease is characterised by a loss of small pulmonary vessels on quantitative CT
(Your Name) has sent you a message from European Respiratory Society
(Your Name) thought you would like to see the European Respiratory Society web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Print
Citation Tools
Severe pulmonary hypertension associated with lung disease is characterised by a loss of small pulmonary vessels on quantitative CT
Dheyaa Alkhanfar, Yousef Shahin, Faisal Alandejani, Krit Dwivedi, Samer Alabed, Chris Johns, Allan Lawrie, AA Roger Thompson, Alexander MK Rothman, Juerg Tschirren, Johanna M Uthoff, Eric Hoffman, Robin Condliffe, Jim M Wild, David G Kiely, Andrew J Swift
ERJ Open Research Jan 2022, 00503-2021; DOI: 10.1183/23120541.00503-2021

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Severe pulmonary hypertension associated with lung disease is characterised by a loss of small pulmonary vessels on quantitative CT
Dheyaa Alkhanfar, Yousef Shahin, Faisal Alandejani, Krit Dwivedi, Samer Alabed, Chris Johns, Allan Lawrie, AA Roger Thompson, Alexander MK Rothman, Juerg Tschirren, Johanna M Uthoff, Eric Hoffman, Robin Condliffe, Jim M Wild, David G Kiely, Andrew J Swift
ERJ Open Research Jan 2022, 00503-2021; DOI: 10.1183/23120541.00503-2021
del.icio.us logo Digg logo Reddit logo Technorati logo Twitter logo CiteULike logo Connotea logo Facebook logo Google logo Mendeley logo
Full Text (PDF)

Jump To

  • Article
    • Abstract
  • Info & Metrics
  • PDF

Subjects

  • Pulmonary vascular disease
  • Lung imaging
  • Tweet Widget
  • Facebook Like
  • Google Plus One

More in this TOC Section

  • Haemodynamic effects of initial combination therapy in pulmonary arterial hypertension: a systematic review and meta-analysis
  • Analysis of real-world data and a mouse model indicates that pirfenidone causes pellagra
  • Functional clinical impairments and frailty in interstitial lung diseases patients
Show more Original research article

Related Articles

Navigate

  • Home
  • Current issue
  • Archive

About ERJ Open Research

  • Editorial board
  • Journal information
  • Press
  • Permissions and reprints
  • Advertising

The European Respiratory Society

  • Society home
  • myERS
  • Privacy policy
  • Accessibility

ERS publications

  • European Respiratory Journal
  • ERJ Open Research
  • European Respiratory Review
  • Breathe
  • ERS books online
  • ERS Bookshop

Help

  • Feedback

For authors

  • Instructions for authors
  • Publication ethics and malpractice
  • Submit a manuscript

For readers

  • Alerts
  • Subjects
  • RSS

Subscriptions

  • Accessing the ERS publications

Contact us

European Respiratory Society
442 Glossop Road
Sheffield S10 2PX
United Kingdom
Tel: +44 114 2672860
Email: journals@ersnet.org

ISSN

Online ISSN: 2312-0541

Copyright © 2022 by the European Respiratory Society